Survival outcomes of patients newly diagnosed with diffuse large B-cell lymphoma: real-world evidence from a German claims database.
Peter BorchmannJan-Michel HegerJoerg MahlichMichael S PapadimitriousSybille RiouBarbara WernerPublished in: Journal of cancer research and clinical oncology (2023)
DLBCL-associated mortality is still high, especially in relapsed patients and in the elderly. Therefore, there is a high medical need for new effective treatments that can improve survival outcomes in DLBCL patients.
Keyphrases
- newly diagnosed
- diffuse large b cell lymphoma
- end stage renal disease
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- healthcare
- prognostic factors
- epstein barr virus
- acute lymphoblastic leukemia
- cardiovascular disease
- patient reported outcomes
- acute myeloid leukemia
- risk factors
- cardiovascular events
- community dwelling